台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    92.5
  • 漲跌
    ▲0.9
  • 漲幅
    +0.98%
  • 成交量
    1,142
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
中裕 (4147)籌碼相關-群益金鼎-新莊 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0404/2005/0405/1805/3006/0806/2207/0407/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1212/2001/0401/1602/0402/1202/2003/0403/1203/1480859095100105110May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

群益金鼎-新莊 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/13192.3000.0091.6012,0990.05%
2025/03/030.194.2000.0094.200.11,8870.01%
2025/02/27496.38295.8595.5021,8780.11%
2025/02/25199.3000.0099.3011,8560.05%
2025/02/241102.501100.0099.3001,7960.00%
2025/02/2100.001104.0098.90-11,727-0.06%
2025/02/2000.00299.1099.70-21,553-0.13%
2025/02/1900.00196.1095.20-11,510-0.07%
2025/02/18496.65194.0094.0031,4910.20%
2025/02/1700.001.2107.2497.10-1.21,440-0.08%
2025/02/0700.00190.1090.10-11,125-0.09%
2025/01/1600.00287.3086.50-21,133-0.18%
2025/01/14187.1000.0087.3011,1470.09%
2025/01/1300.00193.9089.90-11,132-0.09%
2025/01/09391.0300.0087.5031,0140.30%
2025/01/08298.1022.4101.0297.20-20.4872-2.34%
2025/01/0700.00192.0092.70-1649-0.15%
2024/10/28183.8000.0081.0015840.17%
2024/10/2200.00378.2080.60-3562-0.53%
2024/10/18373.6000.0073.6035840.51%
2024/10/16074.3000.0074.2006060.00%
2024/10/0100.000.379.7079.40-0.3635-0.04%
2024/09/1800.00181.4081.40-1665-0.15%
2024/08/29183.50184.2084.4007340.00%
2024/08/2700.00082.1082.0007390.00%
2024/08/1500.00380.0080.00-3775-0.39%
2024/08/13377.4000.0077.8037790.38%
2024/08/0900.00179.3078.40-1785-0.13%
2024/08/05174.0000.0074.0017340.14%
2024/08/02083.5000.0082.2007080.00%
2024/07/2600.00486.0585.80-4735-0.54%
2024/07/22490.0500.0087.1047450.54%
2024/07/1800.00288.5088.40-2709-0.28%
2024/07/17288.00388.4388.10-1713-0.14%
2024/07/15086.30186.0086.30-1747-0.13%
2024/07/111.185.7200.0084.901.17650.15%
2024/07/10085.0000.0085.8007830.00%
2024/07/092.884.6000.0084.102.88100.35%
2024/07/042087.1400.0086.90208892.25%
2024/07/03188.0000.0087.4019530.10%
2024/06/24086.8000.0086.7001,1280.00%
2024/06/21188.5000.0088.9011,1210.09%
2024/06/19089.5000.0089.5001,1360.00%
2024/06/13191.30191.1091.0001,1640.00%
2024/06/1100.00193.6091.00-11,182-0.08%
2024/05/2900.001.790.8289.10-1.71,511-0.11%
2024/05/23088.1000.0087.1002,0140.00%
2024/05/21190.2000.0088.0012,1230.05%
2024/05/10086.6000.0086.5002,2850.00%
2024/05/0600.00187.9088.00-12,331-0.04%
2024/04/1700.00188.5087.80-12,356-0.04%
2024/04/15192.0000.0090.1012,3420.04%
2024/04/1200.00394.0094.00-32,339-0.13%
2024/04/11195.7000.0095.8012,3490.04%
2024/04/10196.1000.0093.2012,3390.04%
2024/04/0900.00595.6296.20-52,301-0.22%
2024/04/03291.4500.0090.6022,1950.09%
2024/04/0100.00190.8090.10-12,074-0.05%
2024/03/27388.5000.0088.0032,0400.15%
2024/03/25188.0000.0087.8012,0270.05%
2024/03/2200.00189.0088.80-12,020-0.05%
2024/03/20190.4000.0089.4012,0020.05%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章